Menting SP - Search Results

1

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.

van Huizen AM, Menting SP, Gyulai R, Iversen L, van der Kraaij GE, Middelkamp-Hup MA, Warren RB, Spuls PI; SPIN MTX Consensus Survey Study Group; Schejtman AA, Egeberg A, Firooz A, Kumar AS, Oakley A, Foulkes A, Ramos AMC, Fougerousse AC, Carija A, Akman-Karakas A, Horváth B, Fábos B, Matlock BH, Claréus BW, Castro C, Ferrándiz C, Correa CC, Marchesi C, Goujon C, Gonzalez C, Maldonado-García C, Hong CH, Griffiths CEM, Vestergaard C, Echeverría CM, de la Cruz C, Conrad C, Törocsik D, Drvar DL, Balak D, Jullien D, Appelen D, Kim DH, de Jong EMGJ, El Gamal E, Laffitte E, Mahé E, Sonkoly E, Colombo EP, Vilarrasa E, Willaert F, Novoa FD, Handjani F, Valenzuela F, Vílchez-Márquez F, Gonzalez GO, Krisztián G, Damiani G, Krnjevic-Pezic G, Pellerano G, Carretero G, Hunter HJA, Riad H, Oon HH, Boonen HPJ, Moussa IO, García-Doval I, Csányi I, Brajac I, Turchin I, Grozdev I, Weinberg JM, Nicolopoulos J, Wells J, Lambert JLW, Ingram JR, Prinz JC, de Souza Sittart JA, Sanchez JL, Hsiao JP, Castro-Ayarza JR, Maul JT, van den Reek JMPA, Trcko K, Barber K, Reich K, Gebauer KA, Khobzei K, Maul LV, Massari LP, Fardet L, le Cleach L, Misery L, Chandrashekar L, Muresanu LI, Lecluse L, Skov L, F… See abstract for full author list ➔ van Huizen AM, et al. Among authors: menting sp. JAMA Dermatol. 2022 May 1;158(5):561-572. doi: 10.1001/jamadermatol.2022.0434. JAMA Dermatol. 2022. PMID: 35353175

2

Comment on 'Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study'.

Menting SP, Kleij DV, Rispens T, Spuls PI, Lecluse LL. Menting SP, et al. Br J Dermatol. 2013 Nov;169(5):1170. doi: 10.1111/bjd.12510. Br J Dermatol. 2013. PMID: 23855584 No abstract available.

3

Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up.

Menting SP, van Lümig PP, de Vries AC, van den Reek JM, van der Kleij D, de Jong EM, Spuls PI, Lecluse LL. Menting SP, et al. JAMA Dermatol. 2014 Feb;150(2):130-6. doi: 10.1001/jamadermatol.2013.8347. JAMA Dermatol. 2014. PMID: 24352354

4

Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.

Teunissen MBM, Munneke JM, Bernink JH, Spuls PI, Res PCM, Te Velde A, Cheuk S, Brouwer MWD, Menting SP, Eidsmo L, Spits H, Hazenberg MD, Mjösberg J. Teunissen MBM, et al. Among authors: menting sp. J Invest Dermatol. 2014 Sep;134(9):2351-2360. doi: 10.1038/jid.2014.146. Epub 2014 Mar 21. J Invest Dermatol. 2014. PMID: 24658504 Free article.

5

Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.

Menting SP, Sitaram AS, Bonnerjee-van der Stok HM, de Rie MA, Hooft L, Spuls PI. Menting SP, et al. Br J Dermatol. 2014 Oct;171(4):875-83. doi: 10.1111/bjd.13001. Epub 2014 Aug 21. Br J Dermatol. 2014. PMID: 24673245

6

An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.

van Lümig PP, Menting SP, van den Reek JM, Spuls PI, van Riel PL, van de Kerkhof PC, Fransen J, Kievit W, de Jong EM. van Lümig PP, et al. Among authors: menting sp. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):752-60. doi: 10.1111/jdv.12675. Epub 2014 Sep 17. J Eur Acad Dermatol Venereol. 2015. PMID: 25229823

7

Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation.

Menting SP, Dekker PM, Limpens J, Hooft L, Spuls PI. Menting SP, et al. Acta Derm Venereol. 2016 Jan;96(1):23-8. doi: 10.2340/00015555-2081. Acta Derm Venereol. 2016. PMID: 25721372 Free article. Review.

8

Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment.

Menting SP, Coussens E, Pouw MF, van den Reek JM, Temmerman L, Boonen H, de Jong EM, Spuls PI, Lambert J. Menting SP, et al. JAMA Dermatol. 2015 Jun;151(6):616-22. doi: 10.1001/jamadermatol.2014.5479. JAMA Dermatol. 2015. PMID: 25807311

9

The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting.

Menting SP, van den Reek JM, Baerveldt EM, de Jong EM, Prens EP, Lecluse LL, Wolbink GJ, Van der Kleij D, Spuls PI, Rispens T. Menting SP, et al. Br J Dermatol. 2015 Sep;173(3):855-7. doi: 10.1111/bjd.13834. Epub 2015 Aug 2. Br J Dermatol. 2015. PMID: 25865153 No abstract available.

10

Potential serum biomarkers of treatment response to ustekinumab in patients with psoriasis: a pilot study.

Onderdijk AJ, Ijpma AS, Menting SP, Baerveldt EM, Prens EP. Onderdijk AJ, et al. Among authors: menting sp. Br J Dermatol. 2015 Dec;173(6):1536-9. doi: 10.1111/bjd.13997. Epub 2015 Nov 25. Br J Dermatol. 2015. PMID: 26134667 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page